Hologic (HOLX)
(Delayed Data from NSDQ)
$76.71 USD
-0.48 (-0.62%)
Updated Apr 24, 2024 04:00 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Income Statements
Fiscal Year end for Hologic, Inc falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 4,030 | 4,863 | 5,632 | 3,776 | 3,367 |
Cost Of Goods | 1,959 | 1,865 | 1,837 | 1,549 | 2,196 |
Gross Profit | 2,072 | 2,997 | 3,796 | 2,228 | 1,171 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,403 | 1,357 | 1,316 | 1,123 | 1,295 |
Income After Depreciation & Amortization | 668 | 1,640 | 2,480 | 1,105 | -124 |
Non-Operating Income | 119 | 43 | -26 | 13 | 7 |
Interest Expense | 111 | 95 | 94 | 117 | 141 |
Pretax Income | 676 | 1,588 | 2,361 | 1,002 | -258 |
Income Taxes | 220 | 286 | 491 | -109 | -54 |
Minority Interest | 0 | 0 | -2 | -5 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 456 | 1,302 | 1,870 | 1,111 | -204 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 456 | 1,302 | 1,872 | 1,115 | -204 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 992 | 2,070 | 2,887 | 1,481 | 339 |
Depreciation & Amortization (Cash Flow) | 323 | 430 | 407 | 376 | 463 |
Income After Depreciation & Amortization | 668 | 1,640 | 2,480 | 1,105 | -124 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 248.83 | 253.85 | 259.71 | 264.61 | 269.41 |
Diluted EPS Before Non-Recurring Items | 3.96 | 6.02 | 8.41 | 3.98 | 2.43 |
Diluted Net EPS (GAAP) | 1.83 | 5.13 | 7.21 | 4.21 | -0.76 |
Fiscal Year end for Hologic, Inc falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,013.10 | 945.30 | 984.40 | 1,026.50 |
Cost Of Goods | NA | 445.60 | 445.00 | 616.90 | 440.70 |
Gross Profit | NA | 567.50 | 500.30 | 367.50 | 585.80 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 369.30 | 367.80 | 366.10 | 313.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 198.20 | 132.50 | 1.40 | 272.10 |
Non-Operating Income | NA | 19.10 | 41.20 | 38.40 | 34.40 |
Interest Expense | NA | 26.00 | 28.10 | 27.70 | 27.20 |
Pretax Income | NA | 191.30 | 145.60 | 12.10 | 279.30 |
Income Taxes | NA | -55.20 | 55.00 | 52.60 | 60.80 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 246.50 | 90.60 | -40.50 | 218.50 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 246.50 | 90.60 | -40.50 | 218.50 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 240.21 | 247.14 | 246.91 | 249.79 |
Diluted EPS Before Non-Recurring Items | NA | 0.98 | 0.89 | 0.93 | 1.06 |
Diluted Net EPS (GAAP) | NA | 1.03 | 0.37 | -0.16 | 0.87 |